| abstract |
The present invention relates to extended benzamide derivatives of general formula I, in the A is a C 6 -C 12 -aryl or C 5 -C 12 -heteroaryl radical which may optionally be monosubstituted or polysubstituted by R 4 and / or R 5 , R 1 is a C 1 -C 6 -alkyl radical which may optionally be substituted, R 2 is a hydrogen, halogen, cyano, a -S (O) q -CH 3 , wherein q is 0-2, a C 1 -C 4 alkoxy or C 1 -C 6 alkyl, said radical being substituted as desired can be, R 3 is a hydrogen, a C 1 -C 6 -alkyl radical, cyano, chlorine or bromine, and Y is a - (CH 2 ) n group, where n is 1 to 3, Process for their preparation and their use for the preparation of pharmaceutical agents for the treatment of diseases and indications associated with the EP 2 receptor. |